Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's diseaseJeffrey C. Barrett, Jilur Ghori, Sarah Hansoul et al.|Nature Genetics|2008Cited by 2.6k
Common variants in the NLRP3 region contribute to Crohn's disease susceptibilityAlexandra–Chloé Villani, Denis Franchimont, Paul Rutgeerts et al.|Nature Genetics|2008Cited by 523
Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trialPaul Rutgeerts, Freddy Penninckx|Gastroenterology|2005Cited by 419
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic ResectionMiguel Regueiro, Pierre Desreumaux, Brian G. Feagan et al.|Gastroenterology|2016Cited by 329
Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab TreatmentIngrid Arijs, Paul Rutgeerts|PLoS ONE|2009Cited by 303